Bausch Health Companies Inc. (NYSE:BHC) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. boosted its position in Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 1.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,487,768 shares of the company's stock after purchasing an additional 175,489 shares during the quarter. Vanguard Group Inc. owned approximately 3.15% of Bausch Health Companies worth $94,429,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Lazard Asset Management LLC acquired a new stake in shares of Bausch Health Companies in the 2nd quarter worth $49,000. Graham Capital Management L.P. purchased a new stake in shares of Bausch Health Companies during the second quarter worth about $84,000. FMR LLC increased its holdings in shares of Bausch Health Companies by 58.3% during the second quarter. FMR LLC now owns 10,057 shares of the company's stock valued at $84,000 after acquiring an additional 3,703 shares in the last quarter. Ausdal Financial Partners Inc. acquired a new position in shares of Bausch Health Companies during the third quarter valued at about $86,000. Finally, Jump Financial LLC purchased a new position in shares of Bausch Health Companies in the 3rd quarter valued at approximately $92,000. 78.65% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on BHC shares. Royal Bank of Canada upped their price target on shares of Bausch Health Companies from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Friday. Jefferies Financial Group lowered their price target on Bausch Health Companies from $16.00 to $14.00 and set a "buy" rating for the company in a research report on Tuesday, February 20th. Finally, StockNews.com raised Bausch Health Companies from a "hold" rating to a "buy" rating in a report on Wednesday, February 7th.

Bausch Health Companies Trading Up 3.6 %

Shares of BHC stock traded up $0.36 during trading hours on Friday, hitting $10.41. The company's stock had a trading volume of 4,469,500 shares, compared to its average volume of 2,513,699. The stock has a market cap of $3.80 billion, a PE ratio of -6.35 and a beta of 0.85. Bausch Health Companies Inc. has a 12-month low of $5.57 and a 12-month high of $11.46. The company has a 50 day moving average of $9.08 and a 200 day moving average of $8.09.

Bausch Health Companies (NYSE:BHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.01 by $0.14. The company had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.29 billion. Bausch Health Companies had a negative net margin of 6.76% and a positive return on equity of 5,147.48%. The firm's revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the company earned $1.02 earnings per share. As a group, analysts anticipate that Bausch Health Companies Inc. will post 3.95 earnings per share for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.